Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma

Affiliations

• ¹ Queensland University of Technology, Centre for Biomedical Technologies, Faculty of Health, School of Biomedical Sciences, Saliva & Liquid Biopsy Translational Laboratory, Queensland 4059, Australia; Translational Research Institute, Queensland 4102, Australia; Nankai University, TEDA School of Biological Sciences and Biotechnology, Tianjin 300457, PR China; Nankai University, Nankai International Advanced Research Institute (Shenzhen Futian), Shenzhen, Guangdong 518045, PR China. Electronic address: kaidun.tang@nankai.edu.cn.
• ² Queensland University of Technology, Centre for Biomedical Technologies, Faculty of Health, School of Biomedical Sciences, Saliva & Liquid Biopsy Translational Laboratory, Queensland 4059, Australia; Translational Research Institute, Queensland 4102, Australia.
• ³ Griffith University, Menzies Health Institute Queensland, School of Pharmacy and Medical Sciences, Queensland 4222, Australia; Griffith University, Menzies Health Institute Queensland, Systems Biology and Data Science, Queensland 4222, Australia; Griffith University, Institute for Glycomics, Queensland 4215, Australia.
• ⁴ QIMR Berghofer Medical Research Institute, Statistics Unit, Queensland 4006, Australia.
• ⁵ Griffith University, Menzies Health Institute Queensland, School of Pharmacy and Medical Sciences, Queensland 4222, Australia; Griffith University, Menzies Health Institute Queensland, Systems Biology and Data Science, Queensland 4222, Australia.
• ⁶ Griffith University, Menzies Health Institute Queensland, School of Pharmacy and Medical Sciences, Queensland 4222, Australia.
• ⁷ Royal Brisbane and Women's Hospital, Oral and Maxillofacial Surgery Department, Queensland 4029, Australia.
• ⁸ Royal Brisbane and Women's Hospital, Department of Otolaryngology, Queensland 4029, Australia.
• ⁹ Royal Brisbane and Women's Hospital, Department of Cancer Care Services, Queensland 4029, Australia; The University of Queensland, School of Medicine, Queensland 4072, Australia; Central Integrated Regional Cancer Service, Queensland Health, Queensland 4001, Australia.
• ¹⁰ Queensland University of Technology, Centre for Biomedical Technologies, Faculty of Health, School of Biomedical Sciences, Saliva & Liquid Biopsy Translational Laboratory, Queensland 4059, Australia; Translational Research Institute, Queensland 4102, Australia; Griffith University, Griffith Institute for Drug Discovery (GRIDD) and Menzies Health Institute Queensland (MIHQ), Saliva and Liquid Biopsy Translational Laboratory, Queensland 4222, Australia. Electronic address: c.punyadeera@griffith.edu.au.